Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Oct 15;100(8):1919–1927. doi: 10.1172/JCI119722

Myocardial insulin resistance in patients with syndrome X.

H E Botker 1, N Moller 1, O Schmitz 1, J P Bagger 1, T T Nielsen 1
PMCID: PMC508380  PMID: 9329954

Abstract

Insulin resistance is common in patients with angina pectoris, a positive exercise electrocardiogram, and normal coronary angiograms (syndrome X). It is still not known whether insulin resistance affects the cardiac muscle itself and, if so, whether insulin resistance involves myocardial hemodynamics and energy metabolism. We investigated hemodynamics as well as metabolite exchanges across the heart and the forearm in eight patients with syndrome X and eight control subjects during a baseline period after an overnight fast and during a hyperinsulinemic-euglycemic clamp. Myocardial hemodynamics and metabolism were studied at rest, during pace stress, and in the recovery period after pacing. Neither coronary sinus blood flow nor forearm blood flow differed between the groups before and during the clamp. Whole body insulin-stimulated glucose uptake was decreased in the patients (15.6+/-2.1 vs. 23.1+/-2.0 micromol x kg-1 x min-1). Insulin-stimulated glucose uptake in the forearm and the cardiac muscle was equally reduced in the patients (46+/-5 and 48+/-5%). Myocardial glucose uptake correlated with total arterial delivery in the control subjects (r = 0.63, P < 0.01), but not in patients (r = 0.22, P = 0.13). Carbohydrate and lipid oxidation was similar in the two groups at rest, and changes during the clamp were not different in control subjects and patients either at rest, during pacing, or in the recovery period. Patients with syndrome X exhibit myocardial insulin resistance, but cardiac energy metabolism remains unaffected. In patients with syndrome X, insulin-stimulated glucose uptake is independent from myocardial blood flow.

Full Text

The Full Text of this article is available as a PDF (231.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen L., Dinesen B., Jørgensen P. N., Poulsen F., Røder M. E. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem. 1993 Apr;39(4):578–582. [PubMed] [Google Scholar]
  2. Bagger J. P. Coronary sinus blood flow determination by the thermodilution technique: influence of catheter position and respiration. Cardiovasc Res. 1985 Jan;19(1):27–31. doi: 10.1093/cvr/19.1.27. [DOI] [PubMed] [Google Scholar]
  3. Baron A. D. Hemodynamic actions of insulin. Am J Physiol. 1994 Aug;267(2 Pt 1):E187–E202. doi: 10.1152/ajpendo.1994.267.2.E187. [DOI] [PubMed] [Google Scholar]
  4. Bøtker H. E., Böttcher M., Schmitz O., Gee A., Hansen S. B., Cold G. E., Nielsen T. T., Gjedde A. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose. J Nucl Cardiol. 1997 Mar-Apr;4(2 Pt 1):125–132. doi: 10.1016/s1071-3581(97)90061-1. [DOI] [PubMed] [Google Scholar]
  5. Bøtker H. E., Møller N., Ovesen P., Mengel A., Schmitz O., Orskov H., Bagger J. P. Insulin resistance in microvascular angina (syndrome X) Lancet. 1993 Jul 17;342(8864):136–140. doi: 10.1016/0140-6736(93)91344-l. [DOI] [PubMed] [Google Scholar]
  6. Bøtker H. E., Sonne H. S., Bagger J. P., Nielsen T. T. Impact of impaired coronary flow reserve and insulin resistance on myocardial energy metabolism in patients with syndrome X. Am J Cardiol. 1997 Jun 15;79(12):1615–1622. doi: 10.1016/s0002-9149(97)00209-9. [DOI] [PubMed] [Google Scholar]
  7. Bøtker H. E., Sonne H. S., Sørensen K. E. Frequency of systemic microvascular dysfunction in syndrome X and in variant angina. Am J Cardiol. 1996 Jul 15;78(2):182–186. [PubMed] [Google Scholar]
  8. Camici P. G., Marraccini P., Lorenzoni R., Buzzigoli G., Pecori N., Perissinotto A., Ferrannini E., L'Abbate A., Marzilli M. Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. J Am Coll Cardiol. 1991 Jun;17(7):1461–1470. doi: 10.1016/0735-1097(91)90632-j. [DOI] [PubMed] [Google Scholar]
  9. Cannon R. O., 3rd, Camici P. G., Epstein S. E. Pathophysiological dilemma of syndrome X. Circulation. 1992 Mar;85(3):883–892. doi: 10.1161/01.cir.85.3.883. [DOI] [PubMed] [Google Scholar]
  10. DeFronzo R. A. Obesity is associated with impaired insulin-mediated potassium uptake. Metabolism. 1988 Feb;37(2):105–108. doi: 10.1016/s0026-0495(98)90001-4. [DOI] [PubMed] [Google Scholar]
  11. Egashira K., Inou T., Hirooka Y., Yamada A., Urabe Y., Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993 Jun 10;328(23):1659–1664. doi: 10.1056/NEJM199306103282302. [DOI] [PubMed] [Google Scholar]
  12. Feldman R. D., Bierbrier G. S. Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet. 1993 Sep 18;342(8873):707–709. doi: 10.1016/0140-6736(93)91708-t. [DOI] [PubMed] [Google Scholar]
  13. Ferrannini E., Santoro D., Bonadonna R., Natali A., Parodi O., Camici P. G. Metabolic and hemodynamic effects of insulin on human hearts. Am J Physiol. 1993 Feb;264(2 Pt 1):E308–E315. doi: 10.1152/ajpendo.1993.264.2.E308. [DOI] [PubMed] [Google Scholar]
  14. Ferrannini E., Taddei S., Santoro D., Natali A., Boni C., Del Chiaro D., Buzzigoli G. Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. Am J Physiol. 1988 Dec;255(6 Pt 1):E953–E958. doi: 10.1152/ajpendo.1988.255.6.E953. [DOI] [PubMed] [Google Scholar]
  15. Fuh M. M., Jeng C. Y., Young M. M., Sheu W. H., Chen Y. D., Reaven G. M. Insulin resistance, glucose intolerance, and hyperinsulinemia in patients with microvascular angina. Metabolism. 1993 Sep;42(9):1090–1092. doi: 10.1016/0026-0495(93)90264-o. [DOI] [PubMed] [Google Scholar]
  16. Goodwin G. W., Ahmad F., Taegtmeyer H. Preferential oxidation of glycogen in isolated working rat heart. J Clin Invest. 1996 Mar 15;97(6):1409–1416. doi: 10.1172/JCI118561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gray D. S., Bray G. A., Gemayel N., Kaplan K. Effect of obesity on bioelectrical impedance. Am J Clin Nutr. 1989 Aug;50(2):255–260. doi: 10.1093/ajcn/50.2.255. [DOI] [PubMed] [Google Scholar]
  18. Hariharan R., Bray M., Ganim R., Doenst T., Goodwin G. W., Taegtmeyer H. Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation. 1995 May 1;91(9):2435–2444. doi: 10.1161/01.cir.91.9.2435. [DOI] [PubMed] [Google Scholar]
  19. Henning S. L., Wambolt R. B., Schönekess B. O., Lopaschuk G. D., Allard M. F. Contribution of glycogen to aerobic myocardial glucose utilization. Circulation. 1996 Apr 15;93(8):1549–1555. doi: 10.1161/01.cir.93.8.1549. [DOI] [PubMed] [Google Scholar]
  20. Koivisto V. A., Yki-Järvinen H., DeFronzo R. A. Physical training and insulin sensitivity. Diabetes Metab Rev. 1986;1(4):445–481. doi: 10.1002/dmr.5610010407. [DOI] [PubMed] [Google Scholar]
  21. Mueckler M. Family of glucose-transporter genes. Implications for glucose homeostasis and diabetes. Diabetes. 1990 Jan;39(1):6–11. doi: 10.2337/diacare.39.1.6. [DOI] [PubMed] [Google Scholar]
  22. Myers J., Froelicher V. F. Exercise testing. Procedures and implementation. Cardiol Clin. 1993 May;11(2):199–213. [PubMed] [Google Scholar]
  23. Nihoyannopoulos P., Kaski J. C., Crake T., Maseri A. Absence of myocardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol. 1991 Nov 15;18(6):1463–1470. doi: 10.1016/0735-1097(91)90676-z. [DOI] [PubMed] [Google Scholar]
  24. Nuutila P., Knuuti J., Ruotsalainen U., Koivisto V. A., Eronen E., Teräs M., Bergman J., Haaparanta M., Voipio-Pulkki L. M., Viikari J. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. Am J Physiol. 1993 May;264(5 Pt 1):E756–E762. doi: 10.1152/ajpendo.1993.264.5.E756. [DOI] [PubMed] [Google Scholar]
  25. Nuutila P., Mäki M., Laine H., Knuuti M. J., Ruotsalainen U., Luotolahti M., Haaparanta M., Solin O., Jula A., Koivisto V. A. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest. 1995 Aug;96(2):1003–1009. doi: 10.1172/JCI118085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Paternostro G., Camici P. G., Lammerstma A. A., Marinho N., Baliga R. R., Kooner J. S., Radda G. K., Ferrannini E. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest. 1996 Nov 1;98(9):2094–2099. doi: 10.1172/JCI119015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Poole-Wilson P. A. Potassium and the heart. Clin Endocrinol Metab. 1984 Jul;13(2):249–268. doi: 10.1016/s0300-595x(84)80021-3. [DOI] [PubMed] [Google Scholar]
  28. Rasmussen K., Bagger J. P., Bøttzauw J., Henningsen P. Prevalence of vasospastic ischaemia induced by the cold pressor test or hyperventilation in patients with severe angina. Eur Heart J. 1984 May;5(5):354–361. doi: 10.1093/oxfordjournals.eurheartj.a061668. [DOI] [PubMed] [Google Scholar]
  29. Reichek N., Helak J., Plappert T., Sutton M. S., Weber K. T. Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. Circulation. 1983 Feb;67(2):348–352. doi: 10.1161/01.cir.67.2.348. [DOI] [PubMed] [Google Scholar]
  30. Romeo F., Rosano G. M., Martuscelli E., Lombardo L., Valente A. Long-term follow-up of patients initially diagnosed with syndrome X. Am J Cardiol. 1993 Mar 15;71(8):669–673. doi: 10.1016/0002-9149(93)91008-6. [DOI] [PubMed] [Google Scholar]
  31. Rosano G. M., Kaski J. C., Arie S., Pereira W. I., Horta P., Collins P., Pileggi F., Poole-Wilson P. A. Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J. 1996 Aug;17(8):1175–1180. doi: 10.1093/oxfordjournals.eurheartj.a015034. [DOI] [PubMed] [Google Scholar]
  32. Swan J. W., Walton C., Godsland I. F., Crook D., Oliver M. F., Stevenson J. C. Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men. Br Heart J. 1994 Jan;71(1):41–44. doi: 10.1136/hrt.71.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Thomassen A. R., Nielsen T. T., Bagger J. P., Henningsen P. Myocardial exchanges of glutamate, alanine and citrate in controls and patients with coronary artery disease. Clin Sci (Lond) 1983 Jan;64(1):33–40. doi: 10.1042/cs0640033. [DOI] [PubMed] [Google Scholar]
  34. Thomassen A., Bagger J. P., Nielsen T. T., Henningsen P. Altered global myocardial substrate preference at rest and during pacing in coronary artery disease with stable angina pectoris. Am J Cardiol. 1988 Oct 1;62(10 Pt 1):686–693. doi: 10.1016/0002-9149(88)91203-9. [DOI] [PubMed] [Google Scholar]
  35. Thomassen A., Nielsen T. T., Bagger J. P., Henningsen P. Cardiac metabolic and hemodynamic effects of insulin in patients with coronary artery disease. Diabetes. 1989 Sep;38(9):1175–1180. doi: 10.2337/diab.38.9.1175. [DOI] [PubMed] [Google Scholar]
  36. Utriainen T., Malmström R., Mäkimattila S., Yki-Järvinen H. Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia. 1995 May;38(5):555–564. doi: 10.1007/BF00400724. [DOI] [PubMed] [Google Scholar]
  37. Voipio-Pulkki L. M., Nuutila P., Knuuti M. J., Ruotsalainen U., Haaparanta M., Teräs M., Wegelius U., Koivisto V. A. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med. 1993 Dec;34(12):2064–2067. [PubMed] [Google Scholar]
  38. Walamies M., Koskinen M., Uusitalo A., Niemelä K. Inhomogeneous exercise uptake and accelerated washout of a radioiodinated fatty acid analogue in syndrome X. A SPECT study of the left ventricle. Int J Card Imaging. 1994 Jun;10(2):123–129. doi: 10.1007/BF01137707. [DOI] [PubMed] [Google Scholar]
  39. Wildenhoff K. E. A micro-method for the enzymatic determination of acetoacetate and 3-hydroxybutyrate in blood and urine. Scand J Clin Lab Invest. 1970 Mar;25(2):171–179. doi: 10.3109/00365517009049200. [DOI] [PubMed] [Google Scholar]
  40. Yki-Järvinen H., Sahlin K., Ren J. M., Koivisto V. A. Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes. 1990 Feb;39(2):157–167. doi: 10.2337/diab.39.2.157. [DOI] [PubMed] [Google Scholar]
  41. Yki-Järvinen H., Young A. A., Lamkin C., Foley J. E. Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest. 1987 Jun;79(6):1713–1719. doi: 10.1172/JCI113011. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES